Journal of Addiction Medicine

Article	Citations
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	83
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	59
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	45
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	44
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	43
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	42
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	41
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	34
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	30
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	29
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	29
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	29
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	29
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	27
Letter to the Editor (RE: Polles et al)	27
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	26
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	26
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	25
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	23
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	22
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	22
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	22
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	20
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	20
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	19

Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	19
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	19
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	18
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	17
Use of Cannabinoids by People Who Consume Kratom in the United States	17
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	17
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	16
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	16
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	16
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	15
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	14
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	14
Fentanyl Test Strips for Harm Reduction: A Scoping Review	13
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	13
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	13
Climate Change and the Opioid Epidemic	13
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	13
Current State of Perioperative Buprenorphine Management—A National Provider Survey	12
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	12
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	12
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	12
The Difficulties in Finding the Relevant Associations between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	11
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	11
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	11
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	11
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	10
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	10
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	10
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	10
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	10
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	9
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	9
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	9
Maternal Cannabis Use in the Perinatal Period: Data From the Pregnancy Risk Assessment Monitoring System Marijuana Supplement, 2016–2018	9
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	9
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	9
Letter in Reply	9
Xylazine Test Strip Use Among People Who Use Drugs in New York State	9
Aripiprazole is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	8
Letter in Reply	8
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	8
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	8

Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	8
Addiction Services for Veterans: Opportunities in Acute Care	8
A Scoping Review of Youth Overdose Prevention Interventions	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	8
Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	8
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	8
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	8
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	7
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	7
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	7
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	7
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	7
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	7
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	7
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	7
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	7
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	7
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	7
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	7
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	7
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	7
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	6
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	6
Response to the Federation of State Physician Health Program's Commentary	6
Direct Induction of Buprenorphine Extended-Release: A Case Report	6
Challenges of Drug Testing in Addiction Treatment	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	6
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	6
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	6
Response to Martins et al.	6
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	6
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	6
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	6
Prevalence of Kratom Use Disorder Among Kratom Consumers	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	5
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	5
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	5
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	5
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	5
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	5
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	5
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	5
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	5
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	5
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	5
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	5
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	5
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	5
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	5
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	5
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	5
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
The First 100 Days: The Trump Administration and Changes to Addiction Policy	5
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	5
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	5
2024 ASAM Annual Conference Poster Abstracts	4
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	4
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	4
A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4

Facilitating Integrated Perinatal Care for Families Affected by Substance Use	4
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	4
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	4
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	4
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	4
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4
The Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60+	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review	4
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	4
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	4
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	4
Does Labetalol Trigger False Positive Drug Testing Results?	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	4
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	4
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	4
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	4
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	4
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	4
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	4
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids Prescr	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	4
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	3
Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder	3
Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study	3
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques	3
Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada	3
Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program	3
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial	3
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain	3
Trends in Characteristics of Prescription Opioid-related Poisonings among Older Adults in the United States, 2015–2021	3
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	3
Physician-approved protocols increase naloxone dispensing rates	3
Buprenorphine Administration and Prescribing at Emergency Departments: A National Analysis From 2014–2021	3
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	3
Findings From Implementing a Patient Experience Survey in a Quality Measurement System for Substance Abuse Disorder Treatment Facilities in 6 States	3
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	3
Phencyclidine Positivity on Urine Drug Screening in Patients Treated for Alcohol Withdrawal on a Dual-diagnosis Medically Assisted Withdrawal Unit	3
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality	3
Secondary Analysis to Advance Characterization of On-body Electrocardiographic Sensors in a Clinical Cocaine Self-administration Paradigm	3
In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care	3
Geographic Trends in Nonfatal Overdose Involving or Exposed to Opioids and Xylazine Across U.S. Emergency Departments	3
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	3
Treating Benzodiazepine Withdrawal in a Bridge Clinic	3
Racial-ethnic Differences in Reasons for Misuse of Prescription Medications Among US Adults	3
Utility of the Global Appraisal of Individual Needs Recommendation and Referral Report for Substance Use Diagnosis, Treatment Planning, and Placement	3
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	3
Drug Testing Interpretation in the Peripartum Setting: Results of Clinician Survey	3
Drug-induced Liver Injury Due to Medications for Alcohol Use Disorder: Results From the DILIN Prospective Study	3
Pregnancy and Pregnancy Outcomes in a National Population Cohort of Patients Treated for Substance Use Disorders	3
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper	3
The Dyadic Association Between Patient Overdose Risk and Family Attitudes Toward Medications for Opioid Use Disorder	3
Injection of Methamphetamine Has Increased in Boston, Massachusetts: 5 Waves of Centers for Disease Control and Prevention State Surveillance Data	3
An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care	3
Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians	3
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	3
The Other Infodemic: Media Misinformation about Involuntary Commitment for Substance Use	3
The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series	3
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes	3
Parent Guidance on Alcohol Use for Youth With Chronic Medical Conditions	3
Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report	3
Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit	3
Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis	3
Implementation of a Naloxone Best Practice Advisory Into an Electronic Health Record	3
Interest in Transcranial Magnetic Stimulation Therapy for Treatment of Depression and Substance Use Disorder Among Peripartum Individuals	3
Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report	3
Maternal Perspective of Inpatient Methadone Initiation: Opportunities to Increase Retention in Treatment	3
The Social Context of Unhealthy Alcohol Use Among Emergency Department Patients: A Cross Sectional Study	3
Successful Transition from Fentanyl to Buprenorphine in a Community-based Withdrawal Management Setting	3
The Howard Street Method: A Community Pharmacy-led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl	3
Financial Well-being and Impact on Alcohol and Mental Health Outcomes During the COVID-19 Pandemic	3
Pediatricians’ Attitudes Toward and Use of Terminology About Mothers With Opioid Use Disorder	3
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT	3
All a-BORG! The Dangerous Drinking Trend Steamrolling Across Social Media and College Campuses	3
Response to Avoiding NICU Transfer for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit	3
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	3
Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers	2
Linking Emergency Services to Chronic Disease Management for Addiction	2
Assessment of COVID-19–Driven Changes in an Integrated OBGYN-Addiction Treatment Clinic and Future Implications	2
Neonate With Intrauterine Xylazine Exposure: A Case Report	2
Substance Use Overdose Deaths Among Black and Indigenous Women in Wisconsin: A Review of Death Certificate Data From 2018 to 2020	2
“Nobody Knows How You’re Supposed to Interpret it:” End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts	2
We Drove to the Moon: Ensuring Methadone Access in Rural Kentucky through Peer Transportation	2
Recovery Capital Correlates With Less Methamphetamine Use and Crime in the Community	2